About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Medical Oncology
›
top-articles
Department of Medical Oncology
29
(top 2%)
papers
896
(top 2%)
citations
15
(top 2%)
h
-index
27
(top 2%)
g
-index
29
all documents
937
doc citations
410
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study
Journal of Clinical Oncology
1999
338
2
Caring for someone with high-grade glioma: a time of rapid change for caregivers
Palliative Medicine
2010
97
3
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
Annals of Oncology
2015
76
4
Tumor‐infiltrating dendritic cells exhibit defective cross‐presentation of tumor antigens, but is reversed by chemotherapy
European Journal of Immunology
2015
64
5
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine
Annals of Oncology
2014
45
6
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
Annals of Oncology
2013
44
7
Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies
Oncotarget
2017
39
8
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
Annals of Oncology
2015
28
9
Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying
Internal Medicine Journal
2018
22
10
Tamoxifen for hepatocellular carcinoma
The Cochrane Library
2004
19
11
Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study
Journal of Clinical Pathology
2014
19
12
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer
Thyroid
2020
19
13
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging
PET Clinics
2011
17
14
Clinical and therapeutic implications of
BRAF
mutation heterogeneity in metastatic melanoma
Pigment Cell and Melanoma Research
2017
16
15
Cancer services in Western Australia: A comparison of regional outcomes with metropolitan Perth
Australian Journal of Rural Health
2015
15
16
EquivocalALKfluorescencein-situhybridization (FISH) cases may benefit from ancillaryALKFISH probe testing
Histopathology
2015
15
17
Treatment of
ALK
‐rearranged non‐small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context
Asia-Pacific Journal of Clinical Oncology
2017
11
18
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET)
Cancer
2017
9
19
A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma
PLoS ONE
2010
9
20
Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia
Internal Medicine Journal
2017
8
21
Small cell lung cancer presenting with paraneoplastic limbic encephalitis
Asia-Pacific Journal of Clinical Oncology
2011
7
22
PathoFusion: An Open-Source AI Framework for Recognition of Pathomorphological Features and Mapping of Immunohistochemical Data
Cancers
2021
6
23
EGFR mutation testing in NSCLC: Patterns of care and outcomes in Western Australia
Asia-Pacific Journal of Clinical Oncology
2009
4
24
Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)
Internal Medicine Journal
2018
3
25
818P Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6
Annals of Oncology
2022
3
26
Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia
Asia-Pacific Journal of Clinical Oncology
2010
2
27
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial
Asia-Pacific Journal of Clinical Oncology
2018
1
28
Tamoxifen for hepatocellular carcinoma
The Cochrane Library
2020
1
29
Treatment of superior sulcus non‐small cell lung cancer
Asia-Pacific Journal of Clinical Oncology
2010
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.